4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-24-015446
Chief Executive Officer sold 60,000 shares at an average $59.26 ($3,555,400)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Santos da Silva Jorge · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-15 | Sale : show line 1 in the form 10b5-1 | −20,000 | $60.18 | $1,203,600 | 3,147,554 | D |
| 2024-02-16 | Sale : show line 2 in the form 10b5-1 | −20,000 | $60.15 | $1,203,000 | 3,127,554 | D |
| 2024-02-20 | Sale : show line 3 in the form 10b5-1 | −20,000 | $57.44 | $1,148,800 | 3,107,554 | D |
| Open-market sales · 60,000 sh · avg $59.26 · $3,555,400 | ||||||
Loading xslF345X05/ownership.xml…